Epidemiological update: Multi-country outbreak of Salmonella Enteritidis infections linked to Polish eggs
Since the joint ECDC-EFSA rapid outbreak assessment ’Multi-country outbreak of Salmonella Enteritidis infections linked to Polish eggs’ published on 12 December 2017, 15 EU/EEA countries (Belgium, Czech Republic, Denmark, France, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Slovenia, Sweden and United Kingdom) have reported 336 confirmed, 94 probable and 3 new historical-confirmed cases associated with this ongoing multi-country outbreak of Salmonella Enteritidis in the EU/EEA. In the same period, seven historical probable cases were reclassified as excluded.
Antimicrobial resistance in zoonotic bacteria still high in humans, animals and food, say ECDC and EFSA
Bacteria from humans and animals continue to show resistance to antimicrobials, according to a new report published today by the European Food Safety Authority and the European Centre for Disease Prevention and Control. The report highlights some emerging issues and confirms antimicrobial resistance as one of the biggest threats to public health. AMR reduces the effectiveness of treatment options.
Salmonella Agona outbreak associated with infant formula milk
On 6 December 2017, France reported an outbreak of Salmonella Agona in infants <1 years of age linked to consumption of infant milk formula based on an epidemiological investigation. Different brands of infant formulas from the same producer in France and distributed to different countries inside and outside the EU were implicated as the vehicle of infection in this outbreak.
Epidemiological update: multi-country outbreak of Salmonella Enteritidis with MLVA profile 2-9-7-3-2 or 2-9-6-3-2 infections
Since the previous ECDC epidemiological update was published on 30 June 2017, seven EU/EEA countries (Belgium, France, Luxembourg, the Netherlands, Norway, Sweden and the United Kingdom) have reported 96 confirmed and 34 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis with MLVA profiles 2-9-7-3-2 or 2-9-6-3-2 ongoing in the EU/EEA.
Epidemiological update: Multi-country outbreak of Salmonella Enteritidis phage type 8, MLVA profile 2-9-7-3-2 and 2-9-6-3-2 infections
Since the ECDC and EFSA joint rapid outbreak assessment was published on 7 March 2017, six EU Member States (Belgium, France, Italy, Norway, Sweden and the United Kingdom) have reported 50 confirmed and 12 probable new cases associated with the multi-country outbreak of Salmonella Enteritidis phage type 8 infections (MLVA profiles 2-9-7-3-2 and 2-9-6-3-2) ongoing in the EU/EEA. In addition, twelve probable cases have been reclassified as confirmed.
Antimicrobial resistance remains high – says EU report
The findings in the latest report on antimicrobial resistance (AMR) in bacteria from ECDC and EFSA underline the serious threat AMR poses to public and animal health. Infections caused by bacteria that are resistant to antimicrobials lead to about 25 000 deaths in the EU every year.
Listeria infections stable but frequently reported among the elderly
There has been a statistically significant increasing trend of listeriosis between 2008 and 2015, with the proportion of cases in the over 64 age group steadily increasing from 56.2% in 2008 to 64.1% in 2015.
Five infectious diseases accounted for 75% of reported cases in EU - summary report
Chlamydia infection, campylobacteriosis, salmonellosis, gonorrhoea and tuberculosis were the most commonly reported notifiable infectious diseases in the EU and EEA in 2014.
Antimicrobial resistance on the rise in the European Union, ECDC and EFSA warn
Bacteria in humans, food and animals continue to show resistance to the most widely used antimicrobials, says the latest report on antimicrobial resistance in zoonotic bacteria in Europe. Resistance to ciprofloxacin, an antimicrobial that is critically important for the treatment of human infections, continues to be very high in Campylobacter, thus reducing the options for effective treatment of severe foodborne infections. In addition, multi-drug resistant Salmonella bacteria continue to spread across Europe.